Keywords: targacept, advance, drug, into, clinicals, clinical-stage, biopharmaceutical

Targacept to advance drug into clinicals

Article | 29 October 2007

Print This

Targacept, a US clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics, says it plans to ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in